Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
Grant for accessing biospecimens and research data from the Population Assessment of Tobacco and Health (PATH) Study on tobacco use in the U.S.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: October 31, 2024 | April 30, 2025 | October 31, 2025 | April 30, 2026 | September 5, 2026
Funding Amounts: No direct funding; award is access to PATH Study biospecimens and data for up to 5 years.
Summary: Provides researchers access to biospecimens and data from the PATH Study to advance tobacco-related research.
Key Information: Applicants must confirm biospecimen availability with PATH Study team at least 5 months before submission.
Description
This opportunity enables researchers to apply for access to biospecimens (urine, plasma, serum, and genomic DNA) and related research data from the Population Assessment of Tobacco and Health (PATH) Study. The PATH Study is a large, nationally representative, longitudinal cohort study of tobacco use and health outcomes in the U.S., designed to inform tobacco regulatory science. Awardees receive access to these resources to conduct meritorious research addressing tobacco use, exposure, biomarkers, and health outcomes, but do not receive direct funding.
